tiprankstipranks
Advertisement
Advertisement

IONS Stock Latest News

Ionis Highlights Positive Long-Term Olezarsen Data in Hypertriglyceridemia
Company AnnouncementsIonis Highlights Positive Long-Term Olezarsen Data in Hypertriglyceridemia
5d ago
8K
IONS
Ionis Pharmaceuticals Adds Veteran Leader to Board
PremiumCompany Announcements
Ionis Pharmaceuticals Adds Veteran Leader to Board
9d ago
8K
IONS
Ionis Pharmaceuticals appoints Hantson to Board of Directors
PremiumThe Fly
Ionis Pharmaceuticals appoints Hantson to Board of Directors
9d ago
IONS
Ionis Pharmaceuticals: Buy Rating Reiterated on Strong Pipeline, Near-Term Catalysts, and Unchanged $110 Price Target
PremiumRatings
Ionis Pharmaceuticals: Buy Rating Reiterated on Strong Pipeline, Near-Term Catalysts, and Unchanged $110 Price Target
12d ago
IONS
Ionis: Bepirovirsen Data Reinforce Underappreciated Partnered Pipeline; Buy Rating and $110 Price Target Reiterated
PremiumRatings
Ionis: Bepirovirsen Data Reinforce Underappreciated Partnered Pipeline; Buy Rating and $110 Price Target Reiterated
19d ago
IONS
Ionis Gains on Positive Phase 3 Hepatitis B Data
PremiumCompany AnnouncementsIonis Gains on Positive Phase 3 Hepatitis B Data
20d ago
8K
IONS
Ionis Pharmaceuticals: Advancing Pipeline, HBV Phase III Success, and Robust Catalyst Flow Underpin Buy Rating
Premium
Ratings
Ionis Pharmaceuticals: Advancing Pipeline, HBV Phase III Success, and Robust Catalyst Flow Underpin Buy Rating
20d ago
IONS
Ionis partner GSK reports B-Well 1, B-Well 2 trials meet primary endpoint
Premium
The Fly
Ionis partner GSK reports B-Well 1, B-Well 2 trials meet primary endpoint
20d ago
GSK
IONS
Ionis Buy Rating Reiterated as Analyst Cites Tryngolza’s Competitive Moat and Confirms Unchanged $125 Price Target
PremiumRatings
Ionis Buy Rating Reiterated as Analyst Cites Tryngolza’s Competitive Moat and Confirms Unchanged $125 Price Target
21d ago
IONS
Citi Names 2 Biotech Stocks ‘Top Picks’ for 2026
PremiumMarket News
Citi Names 2 Biotech Stocks ‘Top Picks’ for 2026
24d ago
CYTK
IONS
StubHub, Jazz Pharmaceuticals upgraded: Wall Street’s top analyst calls
PremiumThe Fly
StubHub, Jazz Pharmaceuticals upgraded: Wall Street’s top analyst calls
29d ago
AMT
BAP
Ionis Pharmaceuticals initiated with a Buy, named a top pick at Citi
PremiumThe Fly
Ionis Pharmaceuticals initiated with a Buy, named a top pick at Citi
30d ago
IONS
Ionis Pharmaceuticals: Buy Rating Reaffirmed as Alzheimer’s Program Advances and Price Target Raised to $111 from $100
PremiumRatingsIonis Pharmaceuticals: Buy Rating Reaffirmed as Alzheimer’s Program Advances and Price Target Raised to $111 from $100
1M ago
IONS
Pelacarsen Phase 3 HORIZON Trial Seen as Key Catalyst Supporting Ionis Buy Rating and Unchanged $105 Price Target
Premium
Ratings
Pelacarsen Phase 3 HORIZON Trial Seen as Key Catalyst Supporting Ionis Buy Rating and Unchanged $105 Price Target
1M ago
IONS
Ionis Pharmaceuticals participates in a conference call with Cantor
Premium
The Fly
Ionis Pharmaceuticals participates in a conference call with Cantor
1M ago
IONS
Biogen’s diranersen shows benefits in early Alzheimer’s Disease
PremiumThe Fly
Biogen’s diranersen shows benefits in early Alzheimer’s Disease
1M ago
BIIB
IONS
Ionis announces Biogen’s CELIA study did not meet primary endpoint
PremiumThe Fly
Ionis announces Biogen’s CELIA study did not meet primary endpoint
1M ago
BIIB
IONS
Ionis Pharmaceuticals price target raised to $111 from $104 at Oppenheimer
PremiumThe Fly
Ionis Pharmaceuticals price target raised to $111 from $104 at Oppenheimer
2M ago
IONS
Ionis Pharmaceuticals price target raised to $86 from $83 at Stifel
PremiumThe Fly
Ionis Pharmaceuticals price target raised to $86 from $83 at Stifel
2M ago
IONS
Ionis Pharmaceuticals price target raised to $100 from $95 at RBC Capital
PremiumThe FlyIonis Pharmaceuticals price target raised to $100 from $95 at RBC Capital
2M ago
IONS
Ionis Pharmaceuticals price target raised to $125 from $120 at H.C. Wainwright
Premium
The Fly
Ionis Pharmaceuticals price target raised to $125 from $120 at H.C. Wainwright
2M ago
IONS
Ionis Pharmaceuticals price target raised to $115 from $106 at Barclays
Premium
The Fly
Ionis Pharmaceuticals price target raised to $115 from $106 at Barclays
2M ago
IONS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >